ABSTRACT Metastasis of nasopharyngeal carcinoma (NPC) to the dura, an extremely rare condition, can be symptomatically silent and mistaken for a benign entity radiographically. Missed diagnosis can lead to serious consequences or prove immediately fatal. We report a woman with dural metastasis of NPC that mimicked a meningioma on radiography. Craniectomy with tumour resection was performed due to rapid progression from the onset of symptoms to disability. The patient was still alive two years after surgery. This case emphasises the need to keep in mind the possibility of dural metastasis of NPC in patients with abnormal imaging features. This would not only avoid wrong and optimistic diagnosis, but also allow for appropriate treatment in a timely manner. To our knowledge, this is the first report of metastasis of NPC to the dura. We provide detailed information on the neoplastic lesion, which masqueraded as a benign entity and caused potentially fatal consequences. NPC has a propensity to develop distant metastases, with an incidence of 17%-53%, and its most common metastatic sites are the bones, lungs and liver.
I NTRO D U C TIO N
Nasopharyngeal carcinoma (NPC), a malignancy highly prevalent in Southeast Asia, (1, 2) tends to develop distant metastases. The most common sites of distant metastasis involved are the bones, lungs and liver. (3) Dural metastasis of NPC is extremely rare and can be symptomatically silent. It can also be mistaken for meningiomas radiographically due to identical dural tail enhancement on magnetic resonance (MR) imaging. (4) This diagnostic dilemma may lead to mistaken identity, which can entail serious consequences or immediate death for the patient. In this study, we report a woman with dural metastasis of NPC that radiographically mimicked a meningioma.
CA S E R E PO RT
A 37-year-old woman was diagnosed with differentiated non- Nausea, vomiting and headaches developed at increasingly closer intervals, which steadily progressed to such an extent that she was unable to perform daily activities. Repeat MR imaging delineated a large space-occupying lesion in the left frontotemporal lobe, resulting in marked brain oedema (Fig. 2) .
However, no recurrent or residual tumour was found at the primary site.
Immediate craniectomy with tumour resection was performed for the patient. Histopathological analysis of the tumour revealed differentiated non-keratinising carcinoma ( Fig. 3a) that had invaded the dura mater while sparing the (Fig. 3b) . The results of histopathological examinations implied dural metastasis from NPC. Two cycles of palliative chemotherapy with paclitaxel and ifosfamide concurrent with radiotherapy to the surgical bed were consequently given to alleviate the physical symptoms and to slow the progress of cancer enough to extend the patient's life. She was still alive two years following surgery.
D I SCU S S IO N

Compared with Western countries, NPC is endemic in Southeast
Asia and hyperendemic in Taiwan, in particular. NPC has a propensity to develop distant metastases, with an incidence of 17%-53%, and its most common metastatic sites are the bones, lungs and liver. (3) Intracranial metastases, found in 25% of patients with malignancies, may be categorised by location as skull, dural, leptomeningeal and brain metastases. 
2a 2b C a s e R e p o r t e84
Brain metastases have been reported to occur in 20%-45% of patients with systemic malignancies, and autopsy reports suggest that about 10% of patients with systemic malignancies have dural metastases. (7) The most common primary sites of dural metastases are the breast, prostate and lungs. (8) Nevertheless, dural metastasis from NPC is exceedingly rare.
The diagnostic challenge presented by dural metastasis of NPC is not only associated with the rarity of dural metastasis from NPC but also because dural metastases can be mistaken for a benign entity both clinically and radiographically. Clinically, about 20% of dural metastases are symptomatically silent and discovered incidentally on radiological workup. (7) Radiographically, although MR imaging is useful in differentiating malignant soft-tissue tumours from benign ones, dural metastases can be mistaken for benign meningiomas that typically have a ragged border, (9) due to identical dural tail signs on MR imaging. (4) As disease progression is rapid, delayed diagnosis of dural metastasis of NPC also means that it might not be possible to perform appropriate surgical intervention in these patients in a timely manner.
With the dural tail sign on follow-up MR imaging as the only clinical indicator, dural metastasis from NPC was not identified early in our patient, causing an increase in intracranial pressure and subsequent neurological complications. Although the missed diagnosis may have led to fatal consequences, tragedy was narrowly avoided in our patient through prompt treatment (i.e. craniectomy and tumour resection).
In conclusion, this report highlights the diagnostic and assessment difficulties clinicians face when dealing with patients diagnosed with NPC following treatment. Clinicians need to maintain a high index of suspicion for dural metastasis in these patients when evidence such as the dural tail sign on repeat MR imaging is present. We recommend that a diagnosis of benign dural lesion be made only if a malignant lesion is excluded.
